Biosimilar Pricing and Competition: Lessons from the US, France and Germany Biosimilar pricing and the challenge of market sustainability Healthcare systems Read More »
Communicate the value How an interactive gene therapy budget impact model produced greater internal understanding and facilitated communication with external stakeholders Read More
Optimize your evidence plan How synthesizing multiple perspectives has enabled the refinement of the market access strategy for four novel cell therapies Read More
